Risk factors for the failure of first‐line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA‐3004)

Abstract Objective To identify the risk factors for failure of first‐line poly (ADP‐ribose) polymerase inhibitor (PARPi) maintenance therapy in patients with advanced ovarian cancer. Method Patients with stage III‐IV epithelial ovarian cancer who received first‐line PARPi maintenance therapy were re...

Cijeli opis

Bibliografski detalji

Glavni autori:	Nam Kyeong Kim, Yeorae Kim, Hee Seung Kim, Soo Jin Park, Dong Won Hwang, Sung Jong Lee, Ji Geun Yoo, Suk‐Joon Chang, Joo‐Hyuk Son, Tae‐Wook Kong, Jeeyeon Kim, Seung‐Hyuk Shim, A Jin Lee, Dong Hoon Suh, Yoo‐Young Lee
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2023-10-01
Serija:	Cancer Medicine
Teme:	first‐line maintenance therapy ovarian cancer poly (ADP‐ribose) polymerase inhibitor recurrence risk factor
Online pristup:	https://doi.org/10.1002/cam4.6546
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!